CAMBRIDGE, Mass.--(BUSINESS WIRE)--On Wednesday, December 19, 2007 after the market closed, Altus Pharmaceuticals Inc. (NASDAQ: ALTU) announced the reacquisition of the ALTU-238 program. In conjunction with this news release, the company will host a conference call to discuss the reacquisition of the ALTU-238 program at 11:00 a.m. ET today, December 20. The call may be joined via telephone by dialing (877) 604-9668 or (719) 325-4904 (for international participants) at least 5 minutes prior to the start of the call. The conference confirmation code is: 2138994. For 72 hours following the call, an audio replay can be accessed by dialing (719) 457-0820 or (888) 203-1112 and using the conference confirmation code 2138994.
